BOTHELL, Wash., Feb. 4 /PRNewswire-FirstCall/ -- Cardiac Science Corporation (Nasdaq: CSCX), a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, accelerated the availability date to February 2010 for the AED software update announced on November 13, 2009, well in advance of the previously estimated May 2010 date.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080306/AQTH510LOGO)

The software will enhance the AEDs' self-test capabilities and improve detection of a component-related issue in certain AEDs manufactured between August 2003 and August 2009. The Company had announced a voluntary field correction on these AEDs on November 13, 2009. In that announcement, the company estimated the software update would be available by May 2010.

The Company has since been able to substantially accelerate the delivery schedule and the software update will now be available to customers of certain models beginning the second half of February. The Company currently anticipates the software update to be available to all affected customers by the end of March 2010.

Customers will be notified by letter when the software update for their affected model is available. The software update will be made available for download at http://www.cardiacscience.com/AED175. At that site, customers who prefer printed documentation and a CD with the software update from the Company may request it.

Cardiac Science President and CEO Dave Marver said, "We have made every effort to accelerate the development of the software update and are pleased to make this field correction available to our customers earlier than expected."

As before, the Company strongly advises customers to follow the normal testing and maintenance procedures found in the Operator and Service Manual. A copy of these procedures is available at http://www.cardiacscience.com/AED175. At this site, customers may confirm if their AED is affected and register for automatic e-mail reminders to conduct scheduled maintenance.

About Cardiac Science

Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AED), electrocardiograph devices (ECG/EKG), cardiac stress treadmill and systems, Holter monitoring systems, hospital defibrillators, vital signs monitors, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The company sells a variety of related products and consumables and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick®, HeartCentrix®, Powerheart®, and Quinton® brands, is headquartered in Bothell, Washington. With customers in more than 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit http://www.cardiacscience.com.

Forward-Looking Statements

This press release contains forward-looking statements. The words "believe," "expect," "intend," "anticipate," variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward-looking. Forward looking statements in this press release include, but are not limited to, predictions concerning the likelihood of AED component failure, and the timing, delivery and effectiveness of the software update described above. These are forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results and performance may vary significantly from those expressed or implied in such statements. Factors that could cause or contribute to such varying results and other risks are more fully described in the Annual Report on Form 10-K filed by Cardiac Science Corporation for the year ended December 31, 2008, as updated by subsequent quarterly reports on Form 10-Q. Cardiac Science Corporation undertakes no duty or obligation to update the information provided herein.

For updates and information on worldwide defibrillation and cardiac monitoring, find us on the Cardiac Science blog at http://www.cardiacscience.com/blog, Twitter at http://twitter.com/cardiacscience, Facebook at http://budurl.com/CSonFB, YouTube at http://www.youtube.com/user/CardiacScience. 


    For more information,
    ---------------------

    Cardiac Science Contact:      Investor Contact:        Media Contact:
    ------------------------      -----------------        --------------
    Mike Matysik                  Matt Clawson             Christopher Gale
    Cardiac Science Corporation   Allen & Caron            EVC Group Inc.
    Senior Vice President and CFO 949.474.4300             646.201.5431
    425.402.2009                  matt@allencaron.com      203.570.4681
                                                           cgale@evcgroup.com

LOGO: http://www.cardiacscience.com/images/main_logo.gif

CSCX-F

SOURCE Cardiac Science Corporation